ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer

Li, Guangyao; Wang, Yandong*; Cheng, Ya*安徽医科大学; 南通大学; 1; y
Journal of Oncology2022-4-29DOI: 10.1155/2022/2043880
3被引4阅读
引用收藏
分享

摘要

Background. Interleukin-2 receptor beta (IL2RB) is a receptor protein of interleukin-2. IL2RB is implicated in regulation of T cell-mediated immune response. However, the role of IL2RB in pan-cancer is unknown. The present premise sought to explore the role of IL2RB in tumorigenesis, tumor metabolism, and tumor immunity in pan-cancer. Methods. Data were retrieved from multiple data resources including GTEx data resource, CCLE data resource, TCGA data resource, UCSC data resource, and TISIDB web server. These data were adopted to assess the expression, prognosis value, relationship between IL2RB and immune microenvironment, microsatellite instability, immune new antigen, gene mutation, immune modulatory factors immune checkpoint and TMB, and immune or molecular subtypes of IL2RB in various tumors. Estimate analysis and GSEA were conducted to assess the role of IL2RB in pan-cancer. Results. Differential analysis illustrated that L2RB was remarkably elevated in pan-cancer, notably in solid tumors compared with normal tissues. Survival analysis indicated that IL2RB was linked to pan-cancer prognosis, and elevated IL2RB contents were remarkably linked to dismal prognosis patients in diverse kinds of cancers. The findings illustrated that IL2RB contents were remarkably linked to tumor immune invasion, tumor microenvironment, TMB, MSI, DNA repair genes, methyl transferases, immune modulatory factors, and immune or molecular subtypes in pan-cancer. IL2RB gene mutation was evident in numerous cancers. The data illustrated that IL2RB contents were remarkably enriched in multiple signaling cascades which modulate tumorigenesis, tumor metabolism along with immunity. Conclusion. The findings of the present premise illustrate that IL2RB plays an indispensible role in tumorigenesis, tumor metabolism, and immunity. Therefore, it is a prospective target gene in tumor-target therapy and tumor immune therapy. IL2RB is also a valuable predictive biomarker in most solid tumors.

学科与关键词

关键词
POLYMORPHISMSEXPRESSIONVARIANTSGENESTIGITCELLSLAG-3CD96
相关
加载中…
  • Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
    Zhang, Haoxun; Liu, Yiwen; Wang, Bowen; Wang, Chunyang*BMC GENOMIC DATA, 2022, 23(1): 58.被引 3
  • Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors
    Cheng, Xin; Cao, Yucheng; Wang, Xiaowei; Cheng, Lin; Liu, Yaqiong; Lei, Jun; Peng, Weijun*; Shi, Dazun*Journal of Immunology Research, 2022, 2022: 5254911.被引 16
  • A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
    Guo, Xuxue; Huang, Mei; Zhang, Haonan; Chen, Qianhui; Hu, Ying; Meng, Yan; Wu, Changjie; Tu, Chenge; Liu, Yongfeng; Li, Aimin; Li, Qingyuan*; Zhou, Peirong*; Liu, Side*Cancer Cell International, 2022, 22(1): 230.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-04-29
卷期
第 2022 卷
页码
2043880
DOI
10.1155/2022/2043880
期刊等级
4区
成果收录
SCIE

作者

  • L

    Li, Guangyao (第一作者)

    nantong univ · 2

  • W

    Wang, Yandong (通讯)

    nantong univ · 2

查看全部 3 位作者收起作者
  • C

    Cheng, Ya (通讯)

    1 · anhui med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417